Can impaired first-phase insulin secretion plus peripheral insulin resistance raise HbA1c despite normal fasting glucose?

In early metabolic dysfunction, a specific phenotype often emerges where fasting glucose levels remain within the normal range, yet HbA1c—the three-month average of blood sugar—begins to rise into prediabetic or even diabetic ranges. This discrepancy is driven by the synergistic failure of two distinct physiological mechanisms: the rapid first-phase insulin response and the efficiency of peripheral glucose disposal.

Clinical and effectiveness evidence

Research indicates that the loss of first-phase insulin secretion (the rapid burst within 10 minutes of glucose ingestion) is one of the earliest detectable defects in the progression toward Type 2 Diabetes.

• Postprandial Excursions: Clinical studies using Continuous Glucose Monitoring (CGM) show that individuals with impaired first-phase secretion experience significantly higher post-meal glucose peaks. These "spikes" contribute disproportionately to the overall glycemic load, even when fasting plasma glucose (FPG) remains under 100 mg/dL.
• HbA1c Discordance: Large-scale longitudinal studies, such as the Baltimore Longitudinal Study of Aging, have identified a subset of patients with "isolated elevated HbA1c." These individuals often have normal fasting glucose but high post-meal glucose (impaired glucose tolerance), leading to an HbA1c in the prediabetic range (5.7%–6.4%).
• The Multiplier Effect: When peripheral insulin resistance coexists with impaired secretion, the impact on postprandial glucose is amplified. The beta-cells cannot mount the necessary early response to compensate for the heightened demand in skeletal muscle, resulting in prolonged periods of hyperglycemia after every meal.

Mechanistic explanations

The synergy between these two impairments creates a metabolic "perfect storm" that targets postprandial control while sparing fasting levels:

• Hepatic Priming: First-phase insulin is critical for "priming" the liver to switch from glucose production to glucose storage. When this phase is absent, hepatic glucose production continues unchecked even as dietary glucose enters the bloodstream.
• Peripheral Clearance: Peripheral insulin resistance, primarily in the skeletal muscle, further slows the clearance of this "double load" of glucose. Mechanistic markers like Asprosin and Fetuin-B have been shown to correlate positively with insulin resistance and negatively with first-phase secretion, providing a molecular link between these two defects.
• Glycation Kinetics: HbA1c reflects the cumulative exposure of red blood cells to glucose. Because post-meal spikes can last several hours and occur multiple times a day, they can elevate the total glycated hemoglobin pool regardless of how low the glucose drops during overnight fasting.

Clinical implications

For patients, particularly those in middle age, relying solely on a fasting glucose test may provide a false sense of security.

• Hidden Prediabetes: The combination of these defects creates a state where metabolic disease is present but "hidden" from standard fasting screens.
• Diagnostic Tools: HbA1c or an Oral Glucose Tolerance Test (OGTT) are more sensitive than fasting glucose for detecting this specific synergistic impairment, as they capture the postprandial excursions driven by the loss of early-phase insulin.

Bottom line

Impaired first-phase insulin secretion and peripheral insulin resistance synergistically drive post-meal glucose spikes that raise HbA1c, often making them the first indicators of metabolic dysfunction while fasting glucose remains deceptively normal.